Open original FDA record ↗Recall record
- FDA identifier
- Z-2206-2016
- Company in FDA record
- RAYSEARCH LABORATORIES AB
- FDA record creation date
- Jul 15, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
An issue was found with the evaluation of biological clinical goals in RayStation 3.0, RayStation 3.5, RayStation 4.0, RayStation 4.5, RayStation 4.7 and RayStation 5. Biological clinical goals for an adapted plan based on another planning CT than the original planning CT will show incorrect values. -- To the best of the firm's knowledge, the issue has not caused any patient mistreatment or other incidents. However, the user must be aware of the following information to avoid incorrect plan evaluation during treatment planning.
Source facts
- Action
- RaySearch Laboratories AB sent Field Safety Notice/Medical Device Correction #11905 Letter (RSL-D-61-298, dated 7/1/2016) to end users via e-mail on 7/1/2016. The letter informs end users of the issue and provides actions to be taken by the users (work around).
- Initiated
- 2016-07-01
- Root cause
- Under Investigation by firm
- Terminated
- 2017-09-25
- Distribution
- California, Connecticut, Delaware, Florida, Hawaii, Maine, Missouri, New York, Ohio, Texas and Washington
- Recall number
- Z-2206-2016
- Recall status
- Terminated
- CDRH record ID
- 148053
- FDA record created
- 2016-07-15
- Recall event number
- 74618